SPONSOR
Institut Claudius Regaud
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 4
Conditions studied: Ependymoma of BrainPediatric Solid TumorSquamous Cell Carcinoma of Head and NeckHead and Neck CancerOvarian CancerCervical CancerCervical Intraepithelial Neoplasia 3Glioblastoma Multiforme of Brain StemNon Small Cell Lung CancerAnal Cancer
Institut Claudius Regaud is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Ependymoma of Brain, Pediatric Solid Tumor, Squamous Cell Carcinoma of Head and Neck, Head and Neck Cancer.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Claudius Regaud
How many clinical trials has Institut Claudius Regaud sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Institut Claudius Regaud, of which 5 are actively recruiting participants. These trials cover conditions including Ependymoma of Brain, Pediatric Solid Tumor, Squamous Cell Carcinoma of Head and Neck. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Claudius Regaud research focus on?
Institut Claudius Regaud clinical trials span Ependymoma of Brain, Pediatric Solid Tumor, Squamous Cell Carcinoma of Head and Neck, Head and Neck Cancer, Ovarian Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut Claudius Regaud clinical trial?
To participate in a Institut Claudius Regaud trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Claudius Regaud trials with current recruitment status updated daily.
Clinical Trials by Institut Claudius Regaud
NCT05151718
Recruiting
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
Ependymoma of Brain
NCT06557889 Phase 2
Recruiting
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
Squamous Cell Carcinoma of Head and Neck
NCT03958240
Recruiting
Deciphering Mechanisms Underlying Cancer Immunogenicity
Head and Neck Cancer
NCT07195344 Phase 4
Recruiting
Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.
Locally Advanced or Metastatic Breast Cancers
NCT07663994
Recruiting
Analytical Validation of Circulating DNA Analysis Methods: Creation of a Control Cohort
Healthy Volunteers (Cancer)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology